Skip to content

Drug interactions

Lapatinib + Quizartinib

Severity: Major

Lapatinib and Quizartinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Quizartinib carries a boxed warning for QT prolongation, torsades de pointes and cardiac arrest, and lapatinib also lengthens the QT interval. Combining them can produce additive QTc prolongation and increases arrhythmia risk.

What this interaction means in plain words

Lapatinib and Quizartinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Lapatinib belongs to Oncology; Quizartinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive pharmacodynamic QT prolongation; lapatinib may also raise quizartinib exposure via weak CYP3A4 inhibition.

What to do

Avoid the combination if possible. If it is unavoidable, monitor ECGs frequently, keep potassium and magnesium normal, and reduce the quizartinib dose or interrupt it according to QTc thresholds in labeling.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lapatinib and Quizartinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lapatinib with Quizartinib?

MediHelp rates the interaction as major. Lapatinib and Quizartinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Quizartinib carries a boxed warning for QT prolongation, torsades de pointes and cardiac arrest, and lapatinib also lengthens the QT interval. Combining them can produce additive QTc prolongation and increases arrhythmia risk.

How serious is the interaction between Lapatinib and Quizartinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination if possible. If it is unavoidable, monitor ECGs frequently, keep potassium and magnesium normal, and reduce the quizartinib dose or interrupt it according to QTc thresholds in labeling.

What other medicines interact with Lapatinib?

MediHelp also lists interactions of Lapatinib with, for example, Dofetilide, Ibutilide, Pimozide. The full list is on the Lapatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in